Pulmonary Hypertension and Vascular Abnormalities in Bronchopulmonary Dysplasia.

[1]  B. Poindexter,et al.  Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. , 2015, American journal of respiratory and critical care medicine.

[2]  J. Padbury,et al.  Pulmonary hypertension in preterm infants: prevalence and association with bronchopulmonary dysplasia. , 2014, The Journal of pediatrics.

[3]  A. Cartón,et al.  Pulmonary hypertension in bronchopulmonary dysplasia: Clinical findings, cardiovascular anomalies and outcomes , 2014, Pediatric pulmonology.

[4]  N. Ambalavanan,et al.  Pulmonary hypertension in bronchopulmonary dysplasia. , 2009, Birth defects research. Part A, Clinical and molecular teratology.

[5]  S. Sims-Lucas,et al.  Histologic evidence of intrapulmonary anastomoses by three-dimensional reconstruction in severe bronchopulmonary dysplasia. , 2013, Annals of the American Thoracic Society.

[6]  J. Francis,et al.  Right Ventricular Systolic Dysfunction in Young Adults Born Preterm , 2013, Circulation.

[7]  S. McGrath-Morrow,et al.  Health-care utilization and respiratory morbidities in preterm infants with pulmonary hypertension , 2013, Journal of Perinatology.

[8]  J. Feinstein,et al.  Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension. , 2013, American journal of respiratory and critical care medicine.

[9]  N. Gotteiner,et al.  Fetal Growth Restriction and Pulmonary Hypertension in Premature Infants with Bronchopulmonary Dysplasia , 2012, Journal of Perinatology.

[10]  C. Blaisdell,et al.  National Heart, Lung, and Blood Institute Workshop: Improving Outcomes for Pulmonary Vascular Disease , 2012, Circulation.

[11]  James O. Mudd,et al.  Pulmonary arterial hypertension: MR imaging-derived first-pass bolus kinetic parameters are biomarkers for pulmonary hemodynamics, cardiac function, and ventricular remodeling. , 2012, Radiology.

[12]  G. Schmalisch,et al.  Persistently Elevated Right Ventricular Index of Myocardial Performance in Preterm Infants with Incipient Bronchopulmonary Dysplasia , 2012, PloS one.

[13]  J. Faber,et al.  eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype. , 2012, Journal of the American Society of Nephrology : JASN.

[14]  W. Carlo,et al.  Prospective Analysis of Pulmonary Hypertension in Extremely Low Birth Weight Infants , 2012, Pediatrics.

[15]  R. Barst,et al.  A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension , 2012, Circulation.

[16]  Yahya Al Ethawi.  Inhaled Nitric Oxide in Preterm Infants Undergoing Mechanical Ventilation , 2012, Journal of clinical neonatology.

[17]  W. Truog,et al.  Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits? , 2012, Journal of Perinatology.

[18]  S. Karumanchi,et al.  Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[19]  J. Slaughter,et al.  Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation , 2011, Journal of Perinatology.

[20]  P. Rozance,et al.  Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[21]  Chang Won Choi,et al.  Risk Factors for Pulmonary Artery Hypertension in Preterm Infants with Moderate or Severe Bronchopulmonary Dysplasia , 2011, Neonatology.

[22]  M. O’Reilly,et al.  Neonatal hyperoxia causes pulmonary vascular disease and shortens life span in aging mice. , 2011, The American journal of pathology.

[23]  P. Jehlička,et al.  Repeated bedside echocardiography in children with respiratory failure , 2011, Cardiovascular ultrasound.

[24]  G. Washko,et al.  Assessment of pulmonary hypertension what CT and MRI can provide. , 2011, Academic radiology.

[25]  B. Poindexter,et al.  Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network , 2010, Pediatrics.

[26]  A. Shennan,et al.  The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application. , 2010, European journal of obstetrics, gynecology, and reproductive biology.

[27]  Q. Mao,et al.  Angiogenesis-related gene expression profiling in ventilated preterm human lungs , 2010, Experimental lung research.

[28]  J. Folkman,et al.  Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. , 2010, The Journal of pediatrics.

[29]  E. Bae,et al.  Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia , 2010, Korean circulation journal.

[30]  D. Cornfield.  Developmental regulation of oxygen sensing and ion channels in the pulmonary vasculature. , 2010, Advances in experimental medicine and biology.

[31]  S. Abman.  Impaired vascular endothelial growth factor signaling in the pathogenesis of neonatal pulmonary vascular disease. , 2010, Advances in experimental medicine and biology.

[32]  E. Kajantie,et al.  Endostatin Concentration in Cord Plasma Predicts the Development of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants , 2009, Pediatrics.

[33]  P. Mourani,et al.  Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. , 2009, The Journal of pediatrics.

[34]  J. Foidarta,et al.  Dysregulation of anti-angiogenic agents ( sFlt-1 , PLGF , and sEndoglin ) in preeclampsia — a step forward but not the definitive answer , 2009 .

[35]  K. Maher,et al.  Pulmonary Vein Stenosis: Prematurity and Associated Conditions , 2008, Pediatrics.

[36]  N. French,et al.  Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia , 2008, European Respiratory Journal.

[37]  S. Abman.  The dysmorphic pulmonary circulation in bronchopulmonary dysplasia: a growing story. , 2008, American journal of respiratory and critical care medicine.

[38]  A. Gest,et al.  Myocardial tissue Doppler changes in patients with bronchopulmonary dysplasia. , 2008, The Journal of pediatrics.

[39]  Egidio Barbi,et al.  Chronic lung disease after premature birth. , 2008, The New England journal of medicine.

[40]  P. Mourani,et al.  Left ventricular diastolic dysfunction in bronchopulmonary dysplasia. , 2008, The Journal of pediatrics.

[41]  P. Mourani,et al.  Clinical Utility of Echocardiography for the Diagnosis and Management of Pulmonary Vascular Disease in Young Children With Chronic Lung Disease , 2008, Pediatrics.

[42]  D. McElhinney,et al.  Pulmonary Artery Hypertension in Formerly Premature Infants With Bronchopulmonary Dysplasia: Clinical Features and Outcomes in the Surfactant Era , 2007, Pediatrics.

[43]  B. Thébaud,et al.  Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. , 2007, American journal of respiratory and critical care medicine.

[44]  Derliz Mereles,et al.  Quantitative 3D pulmonary MR-perfusion in patients with pulmonary arterial hypertension: correlation with invasive pressure measurements. , 2007, European journal of radiology.

[45]  E. Nozik-Grayck,et al.  Role of reactive oxygen species in chronic hypoxia-induced pulmonary hypertension and vascular remodeling. , 2007, Advances in experimental medicine and biology.

[46]  H. Kauczor,et al.  Value of MR phase-contrast flow measurements for functional assessment of pulmonary arterial hypertension , 2007, European Radiology.

[47]  J. Siebert.  Birth defects research part A - Clinical and molecular teratology , 2006 .

[48]  V. Bhandari,et al.  The genetics of bronchopulmonary dysplasia. , 2006, Seminars in perinatology.

[49]  G. Cutter,et al.  Early inhaled nitric oxide therapy in premature newborns with respiratory failure. , 2006, The New England journal of medicine.

[50]  L. Ment,et al.  Familial and Genetic Susceptibility to Major Neonatal Morbidities in Preterm Twins , 2006, Pediatrics.

[51]  P. Dekoninck,et al.  Growth of pulmonary microvasculature in ventilated preterm infants. , 2006, American journal of respiratory and critical care medicine.

[52]  S. Archer,et al.  Vascular Endothelial Growth Factor Gene Therapy Increases Survival, Promotes Lung Angiogenesis, and Prevents Alveolar Damage in Hyperoxia-Induced Lung Injury: Evidence That Angiogenesis Participates in Alveolarization , 2005, Circulation.

[53]  J. Marcus,et al.  Noninvasive assessment and monitoring of the pulmonary circulation , 2005, European Respiratory Journal.

[54]  G. Escobar,et al.  Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002. , 2005, The Journal of pediatrics.

[55]  L. Monte,et al.  [Bronchopulmonary dysplasia]. , 2005, Jornal de pediatria.

[56]  P. Mourani,et al.  Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia. , 2004, American journal of respiratory and critical care medicine.

[57]  G. Escobar,et al.  Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. , 2004, The Journal of pediatrics.

[58]  R. Ryan,et al.  Growth factors in the fetal and neonatal lung. , 2004, Frontiers in bioscience : a journal and virtual library.

[59]  J. Marks,et al.  Inhaled nitric oxide in premature infants with the respiratory distress syndrome. , 2003, The New England journal of medicine.

[60]  D. Ivy,et al.  Acute hemodynamic effects and home therapy using a novel pulsed nasal nitric oxide delivery system in children and young adults with pulmonary hypertension. , 2003, The American journal of cardiology.

[61]  M. Walsh,et al.  Safety, Reliability, and Validity of a Physiologic Definition of Bronchopulmonary Dysplasia , 2003, Journal of Perinatology.

[62]  R. Ehrenkranz,et al.  Statement on the care of the child with chronic lung disease of infancy and childhood. , 2003, American journal of respiratory and critical care medicine.

[63]  J. Coalson.  Pathology of new bronchopulmonary dysplasia. , 2003, Seminars in neonatology : SN.

[64]  A. Jobe.  An unknown: lung growth and development after very preterm birth. , 2002, American journal of respiratory and critical care medicine.

[65]  C. Galambos,et al.  Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms. , 2002, American journal of respiratory cell and molecular biology.

[66]  C. D’Angio,et al.  The role of vascular growth factors in hyperoxia-induced injury to the developing lung. , 2002, Frontiers in bioscience : a journal and virtual library.

[67]  R. Watkins,et al.  Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[68]  P. Heikkilä,et al.  Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. , 2001, American journal of respiratory and critical care medicine.

[69]  R. Watkins,et al.  Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. , 2001, American journal of respiratory and critical care medicine.

[70]  S. Abman.  Bronchopulmonary dysplasia: "a vascular hypothesis". , 2001, American journal of respiratory and critical care medicine.

[71]  N. Voelkel,et al.  Inhibition of angiogenesis decreases alveolarization in the developing rat lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[72]  E. Bancalari,et al.  CLINICAL COURSE AND LUNG FUNCTION ABNORMALITIES DURING DEVELOPMENT OF NEONATAL CHRONIC LUNG DISEASE , 1999 .

[73]  D. Phelps,et al.  Atypical Chronic Lung Disease Patterns in Neonates , 1999, Pediatrics.

[74]  A. Husain,et al.  Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. , 1998, Human pathology.

[75]  W. Teague,et al.  Reduced gas transfer at rest and during exercise in school-age survivors of bronchopulmonary dysplasia. , 1998, American journal of respiratory and critical care medicine.

[76]  A. Sovijärvi,et al.  Diffusing capacity of the lung in school‐aged children born very preterm, with and without bronchopulmonary dysplasia , 1996, Pediatric pulmonology.

[77]  W. Auger,et al.  Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests. , 1996, Chest.

[78]  M. Hack,et al.  Hospitalization as a measure of morbidity among very low birth weight infants with chronic lung disease. , 1996, The Journal of pediatrics.

[79]  E. Bancalari,et al.  Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. , 1996, The Journal of pediatrics.

[80]  E. Bancalari,et al.  Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. , 1995, The Journal of pediatrics.

[81]  M. Silverman,et al.  Pulmonary hypertension in infants with chronic lung disease: non-invasive evaluation and short term effect of oxygen treatment. , 1995, Archives of disease in childhood. Fetal and neonatal edition.

[82]  M. Benders,et al.  Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome. , 1992, Pediatrics.

[83]  J. Skinner,et al.  Pulmonary and systemic arterial pressure in hyaline membrane disease. , 1992, Archives of disease in childhood.

[84]  A. Hislop,et al.  Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease , 1990, Pediatric pulmonology.

[85]  L. Hatle,et al.  Noninvasive estimation of systolic pressure in the right ventricle in patients with tricuspid regurgitation. , 1986, European heart journal.

[86]  J. Seward,et al.  Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. , 1985, Journal of the American College of Cardiology.

[87]  A. Van Tosh,et al.  Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. , 1985, Journal of the American College of Cardiology.

[88]  W. Zapol,et al.  Pulmonary artery remodeling and pulmonary hypertension after exposure to hyperoxia for 7 days. A morphometric and hemodynamic study. , 1984, The American journal of pathology.

[89]  P. Yock,et al.  Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. , 1984, Circulation.

[90]  J. Bucher,et al.  Oxygen-Induced Alterations in Lung Vascular Development in the Newborn Rat , 1983, Pediatric Research.

[91]  J. Fouron,et al.  Value of echocardiography in assessing the outcome of bronchopulmonary dysplasia of the newborn. , 1980, Pediatrics.

[92]  A. Stark,et al.  Bronchopulmonary dysplasia: possible relationship to pulmonary edema. , 1978, The Journal of pediatrics.

[93]  W. Northway,et al.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. , 1967, The New England journal of medicine.